Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Q2 2026 revenue rose 48% to a record $28.3 million, with record net income and adjusted EBITDA plus raised full-year guidance; shares gained 44.6% through August 26, supporting near-term continuation potential.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Margin expansion ⢠Cash conversion ⢠Liability coverage PAYS delivered strong quarterly profitability and liquidity, but weak cash conversion, elevated liabilities, dilution, and sharply higher valuation multiples warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Strong Uptrend ⢠Overbought Momentum ⢠Gap-Up Risk Support Level: $13.00; $12.40â$12.53 Resistance Level: $14.09 PAYS has surged 62% over the last month, but extreme momentum and overbought conditions make consolidation likely unless it holds $13.00 and clears $14.09.
Sentiment & News
Key News Insights: ⢠Record Q2 Results ⢠Guidance Raised ⢠Investor Stake Increased Paysign posted record Q2 growth, raised guidance, and attracted investor interest, though its sector performance remains under comparison.
AI Summary
PAYS has transformed into a fast-growing pharmaceutical-services platform, but its premium valuation now requires sustained program-driven growth and improved cash conversion, making receivables, margins, and execution the key indicators before adding exposure.
Description
Paysign, Inc. provides prepaid card programs, patient affordability services, digital banking tools, and payment processing services for businesses, consumers, and government entities. Its offerings support use cases such as rewards, rebates, incentive payments, healthcare reimbursement, and pharmaceutical assistance, along with cardholder support and digital account access. The company was founded in 2001 and is based in Henderson, Nevada.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Aug 26 | Sep 2 | PAYS | Paysign, Inc. | Q2 2026 revenue rose 48% to a record $28.3 million, with record net income and adjusted EBITDA plus raised full-year guidance; shares gained 44.6% through August 26, supporting near-term continuation potential. | Active | +0.0% |